• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Comment on: The prognostic significance of tumour-stroma ratio in oestrogen receptor-positive breast cancer.

作者信息

Mesker W E, Dekker T J A, de Kruijf E M, Engels C C, van Pelt G W, Smit V T H B M, Tollenaar R A E M

机构信息

Department of Surgery, Leiden University Medical Center (LUMC), Leiden, The Netherlands.

Department of Pathology, Leiden University Medical Center (LUMC), Leiden, The Netherlands.

出版信息

Br J Cancer. 2015 May 26;112(11):1832-3. doi: 10.1038/bjc.2014.570. Epub 2014 Nov 13.

DOI:10.1038/bjc.2014.570
PMID:25393363
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4647256/
Abstract
摘要

相似文献

1
Comment on: The prognostic significance of tumour-stroma ratio in oestrogen receptor-positive breast cancer.关于《雌激素受体阳性乳腺癌中肿瘤-基质比值的预后意义》的评论
Br J Cancer. 2015 May 26;112(11):1832-3. doi: 10.1038/bjc.2014.570. Epub 2014 Nov 13.
2
Reponse to: comment on, 'Tumour-stroma ratio (TSR) in oestrogen-positive breast cancer patients'.对《雌激素受体阳性乳腺癌患者的肿瘤-基质比率（TSR）》评论的回复
Br J Cancer. 2015 May 26;112(11):1833-4. doi: 10.1038/bjc.2014.571. Epub 2014 Nov 13.
3
The prognostic significance of tumour-stroma ratio in oestrogen receptor-positive breast cancer.肿瘤-基质比在雌激素受体阳性乳腺癌中的预后意义。
Br J Cancer. 2014 Apr 2;110(7):1744-7. doi: 10.1038/bjc.2014.69. Epub 2014 Feb 18.
4
PET imaging of oestrogen receptors in patients with breast cancer.乳腺癌患者雌激素受体的 PET 成像。
Lancet Oncol. 2013 Oct;14(11):e465-e475. doi: 10.1016/S1470-2045(13)70292-4.
5
Correlation between tumour characteristics, SUV measurements, metabolic tumour volume, TLG and textural features assessed with F-FDG PET in a large cohort of oestrogen receptor-positive breast cancer patients.一大群雌激素受体阳性乳腺癌患者中肿瘤特征、SUV测量值、代谢肿瘤体积、总病变糖酵解与通过F-FDG PET评估的纹理特征之间的相关性
Eur J Nucl Med Mol Imaging. 2017 Jul;44(7):1145-1154. doi: 10.1007/s00259-017-3641-4. Epub 2017 Feb 10.
6
First evidence supporting a potential role for the BMP/SMAD pathway in the progression of oestrogen receptor-positive breast cancer.支持骨形态发生蛋白/信号转导分子 Mothers Against Decapentaplegic（BMP/SMAD）信号通路在雌激素受体阳性乳腺癌进展中可能发挥作用的首个证据。
J Pathol. 2005 Jul;206(3):366-76. doi: 10.1002/path.1785.
7
Frequency of distribution of oestrogen and progesterone receptors positivities in breast cancer cases in Benin-City, Nigeria.尼日利亚贝宁城乳腺癌病例中雌激素和孕激素受体阳性的分布频率。
Niger Postgrad Med J. 2012 Mar;19(1):19-24.
8
Akt2 expression is associated with good long-term prognosis in oestrogen receptor positive breast cancer.Akt2 表达与雌激素受体阳性乳腺癌的良好长期预后相关。
Eur J Cancer. 2013 Apr;49(6):1196-204. doi: 10.1016/j.ejca.2012.12.006. Epub 2013 Jan 8.
9
Prognostic significance of oestrogen receptor beta in breast cancer.雌激素受体β在乳腺癌中的预后意义。
Br J Surg. 2000 Apr;87(4):405-9. doi: 10.1046/j.1365-2168.2000.01402.x.
10
Prognostic significance of CD8+ T lymphocytes in breast cancer depends upon both oestrogen receptor status and histological grade.CD8+ T 淋巴细胞在乳腺癌中的预后意义取决于雌激素受体状态和组织学分级。
Histopathology. 2011 Jun;58(7):1107-16. doi: 10.1111/j.1365-2559.2011.03846.x. Epub 2011 Jun 24.

引用本文的文献

1
The Prognostic Role of Intratumoral Stromal Content in Lobular Breast Cancer.肿瘤内基质含量在小叶型乳腺癌中的预后作用
Cancers (Basel). 2022 Feb 14;14(4):941. doi: 10.3390/cancers14040941.
2
The prognostic value of tumour-stroma ratio in primary breast cancer with special attention to triple-negative tumours: a review.肿瘤-基质比在原发性乳腺癌中的预后价值，特别关注三阴性肿瘤：综述。
Breast Cancer Res Treat. 2019 Jan;173(1):55-64. doi: 10.1007/s10549-018-4987-4. Epub 2018 Oct 9.
3
Whole transcriptome profiling of patient-derived xenograft models as a tool to identify both tumor and stromal specific biomarkers.将患者来源的异种移植模型的全转录组分析作为一种识别肿瘤和基质特异性生物标志物的工具。
Oncotarget. 2016 Apr 12;7(15):20773-87. doi: 10.18632/oncotarget.8014.

本文引用的文献

1
Intratumoral DNA content heterogeneity in breast carcinomas demonstrated by core punch tissue sampling and flow cytometry.通过芯针穿刺组织取样和流式细胞术显示的乳腺癌瘤内DNA含量异质性
J Clin Pathol. 2014 Sep;67(9):821-4. doi: 10.1136/jclinpath-2014-202418.
2
Mesenchymal precursor cells maintain the differentiation and proliferation potentials of breast epithelial cells.间充质前体细胞维持乳腺上皮细胞的分化和增殖潜能。
Breast Cancer Res. 2014 Jun 10;16(3):R60. doi: 10.1186/bcr3673.
3
Differences between CAFs and their paired NCF from adjacent colonic mucosa reveal functional heterogeneity of CAFs, providing prognostic information.癌相关成纤维细胞（CAFs）与其来自相邻结肠黏膜的配对正常成纤维细胞（NCF）之间的差异揭示了CAFs的功能异质性，提供了预后信息。
Mol Oncol. 2014 Oct;8(7):1290-305. doi: 10.1016/j.molonc.2014.04.006. Epub 2014 May 6.
4
The relationship between tumour stroma percentage, the tumour microenvironment and survival in patients with primary operable colorectal cancer.原发性可手术切除结直肠癌患者的肿瘤基质百分比、肿瘤微环境与生存率之间的关系。
Ann Oncol. 2014 Mar;25(3):644-651. doi: 10.1093/annonc/mdt593. Epub 2014 Jan 23.
5
Tumor-stroma ratio is an independent predictor for survival in early cervical carcinoma.肿瘤间质比是早期宫颈癌生存的独立预测因子。
Gynecol Oncol. 2014 Jan;132(1):81-6. doi: 10.1016/j.ygyno.2013.11.003. Epub 2013 Nov 9.
6
Genes upregulated in prostate cancer reactive stroma promote prostate cancer progression in vivo.前列腺癌反应性基质中上调的基因促进体内前列腺癌的进展。
Clin Cancer Res. 2014 Jan 1;20(1):100-9. doi: 10.1158/1078-0432.CCR-13-1184. Epub 2013 Oct 22.
7
Prognostic significance of the tumor-stroma ratio: validation study in node-negative premenopausal breast cancer patients from the EORTC perioperative chemotherapy (POP) trial (10854).肿瘤间质比的预后意义：来自 EORTC 围手术期化疗（POP）试验（10854）的淋巴结阴性绝经前乳腺癌患者的验证研究。
Breast Cancer Res Treat. 2013 Jun;139(2):371-9. doi: 10.1007/s10549-013-2571-5. Epub 2013 May 25.
8
[Tumor-stroma ratio is an independent prognostic factor of non-small cell lung cancer].肿瘤间质比是非小细胞肺癌的独立预后因素。
Zhongguo Fei Ai Za Zhi. 2013 Apr;16(4):191-6. doi: 10.3779/j.issn.1009-3419.2013.04.04.
9
The proportion of tumor-stroma as a strong prognosticator for stage II and III colon cancer patients: validation in the VICTOR trial.肿瘤间质比例作为 II 期和 III 期结肠癌患者的强预后因素：VICTOR 试验的验证。
Ann Oncol. 2013 Jan;24(1):179-85. doi: 10.1093/annonc/mds246. Epub 2012 Aug 2.
10
Tumor-stroma ratio is an independent predictor for survival in esophageal squamous cell carcinoma.肿瘤间质比是食管鳞癌生存的独立预测因子。
J Thorac Oncol. 2012 Sep;7(9):1457-61. doi: 10.1097/JTO.0b013e318260dfe8.